Target Price | $330.77 |
Price | $334.91 |
Deviation | 1.24% |
Number of Estimates | 26 |
26 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $330.77. This is 1.24% lower than the current stock price. The highest price target is $420.00 25.41% , the lowest is $194.00 42.07% . | |
A rating was issued by 34 analysts: 18 Analysts recommend Lululemon Athletica to buy, 13 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 1.24% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
28 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.2b . This is 6.02% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.5b 8.17% , the lowest is $10.7b 1.44% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.2b | 6.02% |
2027 | $12.1b | 7.55% |
2028 | $12.9b | 7.23% |
2029 | $13.6b | 5.35% |
2030 | $14.4b | 5.90% |
24 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.0b . This is 19.76% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.1b 23.84% , the lowest is $2.7b 8.03% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.5b | 13.55% |
---|---|---|
2026 | $3.0b | 19.64% |
2027 | $3.2b | 6.25% |
2028 | $3.4b | 8.02% |
2029 | $3.7b | 7.08% |
2030 | $4.0b | 7.10% |
2025 | 23.72% | 3.16% |
---|---|---|
2026 | 26.77% | 12.84% |
2027 | 26.45% | 1.20% |
2028 | 26.64% | 0.72% |
2029 | 27.08% | 1.65% |
2030 | 27.39% | 1.14% |
10 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.9b . This is 3.57% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 5.88% , the lowest is $1.7b 8.68% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 17.06% |
---|---|---|
2026 | $1.9b | 3.57% |
2027 | $2.1b | 9.09% |
2028 | $2.1b | 3.72% |
2029 | $2.6b | 24.12% |
2030 | $3.0b | 11.78% |
2025 | 17.14% | 6.35% |
---|---|---|
2026 | 16.74% | 2.32% |
2027 | 16.98% | 1.43% |
2028 | 16.42% | 3.30% |
2029 | 19.35% | 17.84% |
2030 | 20.43% | 5.58% |
10 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $14.87 . This is 0.20% lower than earnings per share in the financial year 2025. The highest EPS forecast is $15.20 2.01% , the lowest is $13.11 12.01% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $14.87 | 1.57% |
2027 | $16.22 | 9.08% |
2028 | $16.82 | 3.70% |
2029 | $20.88 | 24.14% |
2030 | $23.34 | 11.78% |
Current | 22.48 | 9.87% |
---|---|---|
2026 | 22.52 | 0.19% |
2027 | 20.65 | 8.30% |
2028 | 19.91 | 3.58% |
2029 | 16.04 | 19.44% |
2030 | 14.35 | 10.54% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 3.56 and an P/S ratio of 3.74 .
This results in the following potential growth metrics and future valuations:
Current | 3.77 | 4.43% |
---|---|---|
2026 | 3.56 | 5.55% |
2027 | 3.31 | 7.02% |
2028 | 3.09 | 6.74% |
2029 | 2.93 | 5.08% |
2030 | 2.77 | 5.57% |
Current | 3.96 | 4.11% |
---|---|---|
2026 | 3.74 | 5.68% |
2027 | 3.47 | 7.02% |
2028 | 3.24 | 6.74% |
2029 | 3.08 | 5.08% |
2030 | 2.90 | 5.57% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
Telsey Advisory Group |
Outperform
➜
Outperform
|
Unchanged | Jun 02 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | May 29 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | May 28 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 12 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 30 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Apr 28 2025 |
Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Apr 22 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Telsey Advisory Group:
Outperform
➜
Outperform
|
Jun 02 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
May 29 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
May 28 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
May 12 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 30 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Apr 28 2025 |
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Apr 22 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.